Literature DB >> 14664170

[The stomach and duodenum condition in patients with chronic obstructive lung diseases].

T A Fedorova, L Iu Spirina, N E Chernekhovskaia, T D Kanareĭtseva, T I Sotnikova, N V Zhidkova, E L Anchukova.   

Abstract

Examining the gastroduodenal mucosa (GDM) in 61 patients with chronic obstructive pulmonary diseases (COPD) showed changes in the areas studied in all cases. GDM atrophy increased with the severity of COPD. Helicobacter pylori are essential in developing gastric pathology in patients with mild bronchopulmonary disease. The severity of atrophic gastritis increases with the longer duration of COPD and with more severity of hypoxia and bronchial obstruction.

Entities:  

Mesh:

Year:  2003        PMID: 14664170

Source DB:  PubMed          Journal:  Klin Med (Mosk)        ISSN: 0023-2149


  5 in total

Review 1.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

2.  Different gastoroesophageal reflux symptoms of middle-aged to elderly asthma and chronic obstructive pulmonary disease (COPD) patients.

Authors:  Yasuo Shimizu; Kunio Dobashi; Motoyasu Kusano; Masatomo Mori
Journal:  J Clin Biochem Nutr       Date:  2011-11-11       Impact factor: 3.114

3.  Hypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota.

Authors:  Junyue Xing; Yongquan Ying; Chenxi Mao; Yiwei Liu; Tingting Wang; Qian Zhao; Xiaoling Zhang; Fuxia Yan; Hao Zhang
Journal:  Nat Commun       Date:  2018-05-22       Impact factor: 14.919

Review 4.  Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker.

Authors:  Domenico Maurizio Toraldo; Luana Conte
Journal:  J Clin Med Res       Date:  2019-10-04

Review 5.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.